Form 4: Taylor Devices Director Acquires 7,000 Stock Options

Sentiment:

SEC Form 4 Filing


Robert Michael Carey, a director at Taylor Devices, Inc., acquired 7,000 stock options on April 18, 2025.

Summary

  • On April 18, 2025, Robert Michael Carey, a director of Taylor Devices, Inc., acquired 7,000 stock options.
  • The options have an exercise price of $30.55.
  • The options are exercisable from April 18, 2025, and expire on April 18, 2035.
  • Following the transaction, Carey directly owns 7,000 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of a stock option grant to a director. While option grants can be seen as a positive incentive, this filing itself doesn't strongly indicate positive or negative sentiment.

Positives

  • A director's acquisition of stock options can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

This is a standard SEC Form 4 filing, reflecting a change in beneficial ownership of securities. It's common for directors and officers to receive stock options as part of their compensation.

Stakeholder Impact

  • The acquisition of stock options by a director could have a minor positive impact on shareholder sentiment, as it aligns the director's interests with those of the shareholders.

Key Dates

DateDescription
04/18/2025Date of the transaction: acquisition of stock options.
04/18/2025Date the stock options become exercisable.
04/18/2035Expiration date of the stock options.
04/22/2025Date of the Form 4 filing.

Keywords

stock options, Form 4, director, TAYD, Taylor Devices, acquisition

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.